Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on …

J van der Velden, FW Asselbergs… - Cardiovascular …, 2022 - academic.oup.com
Cardiovascular diseases represent a major cause of morbidity and mortality, necessitating
research to improve diagnostics, and to discover and test novel preventive and curative …

Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research

K Andrysiak, J Stępniewski, J Dulak - Pflügers Archiv-European Journal of …, 2021 - Springer
Abstract Development of new drugs is of high interest for the field of cardiac and
cardiovascular diseases, which are a dominant cause of death worldwide. Before being …

Strategies for improving the maturity of human induced pluripotent stem cell-derived cardiomyocytes

C Tu, BS Chao, JC Wu - Circulation research, 2018 - Am Heart Assoc
Tu et al Strategies to Promote Cardiac Maturation 513 in previous iPSC-CM models.
Together, these results indicate an advanced level of maturity, both structurally and …

Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of …

F Zhang, KY Qu, B Zhou, Y Luo, Z Zhu, DJ Pan… - Biosensors and …, 2021 - Elsevier
In vitro model of the human cardiac tissues generated from human induced pluripotent stem
cells (hiPSCs) could facilitate drug discovery and patient-specific studies of physiology and …

Induced pluripotent stem cell-derived cardiomyocyte in vitro models: benchmarking progress and ongoing challenges

JK Ewoldt, SJ DePalma, ME Jewett, MÇ Karakan… - Nature …, 2024 - nature.com
Recent innovations in differentiating cardiomyocytes from human induced pluripotent stem
cells (hiPSCs) have unlocked a viable path to creating in vitro cardiac models. Currently …

Proliferation and maturation: janus and the art of cardiac tissue engineering

BN Singh, D Yucel, BI Garay, EG Tolkacheva… - Circulation …, 2023 - Am Heart Assoc
During cardiac development and morphogenesis, cardiac progenitor cells differentiate into
cardiomyocytes that expand in number and size to generate the fully formed heart. Much is …

Severe cardiac dysfunction and death caused by arrhythmogenic right ventricular cardiomyopathy type 5 are improved by inhibition of glycogen synthase kinase-3β

L Padrón-Barthe, M Villalba-Orero… - Circulation, 2019 - Am Heart Assoc
Background: Arrhythmogenic cardiomyopathy/arrhythmogenic right ventricular
cardiomyopathy (ARVC) is an inherited cardiac disease characterized by fibrofatty …

Step-by-step fabrication of heart-on-chip systems as models for cardiac disease modeling and drug screening

S Deir, YM Mofrad, S Mashayekhan, A Shamloo… - Talanta, 2024 - Elsevier
Cardiovascular diseases are caused by hereditary factors, environmental conditions, and
medication-related issues. On the other hand, the cardiotoxicity of drugs should be …

A myocardial infarct border-zone-on-a-chip demonstrates distinct regulation of cardiac tissue function by an oxygen gradient

ML Rexius-Hall, NN Khalil, SS Escopete, X Li, J Hu… - Science …, 2022 - science.org
After a myocardial infarction, the boundary between the injured, hypoxic tissue and the
adjacent viable, normoxic tissue, known as the border zone, is characterized by an oxygen …

Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk …

SD Burnett, AD Blanchette, WA Chiu… - Expert opinion on drug …, 2021 - Taylor & Francis
Introduction Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes is one of
the most widely used cell-based models that resulted from the discovery of how non …